📰 Use Authorization News
Page 38 - Use Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Authorization. Real-time updates on events, politics, business and more.
December 16, 2021
All of these vaccine stocks benefited from rising concerns about the Omicron variant.
December 14, 2021
/PRNewswire/ -- According to the new market research report "Antibody Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Kits,...
December 14, 2021
-The Antibody Testing Market Size is driven by rising number of COVID-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population. The infectious diseases
December 13, 2021
Concerns about the omicron variant as well as some good news are helping drive these vaccine stocks higher.
December 13, 2021
Concerns about the omicron variant as well as some good news are helping drive these vaccine stocks higher.
December 11, 2021
Smoking gun: Lord Fauci states COVID PCR test has fatal flaw; confession from the “beloved” expert of experts
December 11, 2021
As my readers know, I’ve been proving for well over a year that the SARS-CoV-2 virus doesn’t exist. (Article by Jon Rappoport republished from Blog.NoMoreFakeNews.com) Therefore, any test for it [...]
December 10, 2021
LOS ANGELES—The Los Angeles Unified School District (LAUSD) fired nearly 500 employees for refusing to comply with the ...
December 9, 2021
North Carolina-based Brii Biosciences Limited today announced that China's National Medical Products Administration (NMPA) had approved the company's monoclonal neutralizing antibody therapy, the amubarvimab / romlusevimab combination (BRII-196/BRII-198). Amubarvimab and Romlusevimab are non-competing SARS-CoV-2 monoclonal neutralizing antibodies derived from convalesced COVID-19 patients.